SUMMARY The inhibitory effect of ranitidine and cimetidine on pentagastrin stimulated volume, acid and pepsin secretion has been studied in eight healthy volunteers. Both compounds inhibit all measured components of gastric secretion in a dose dependent manner. On a molar basis ranitidine is on average 1 1-14 times for volume, 13.04 times for acid, and 9.74 times for pepsin secretion more potent than cimetidine as measured by the ID50-values.
Ranitidine has been shown to be a specific and effective histamine H2-receptor antagonist in the standard systems.1 It has also been shown to be a potent inhibitor of gastric acid secretion in man.2-5 Therefore ranitidine, like cimetidine, is a potential therapeutic agent in peptic ulcer disease; however, its therapeutically effective dose compared with that of cimetidine is not known. It was the purpose of the present investigation to study the dose response relationship of ranitidine and cimetidine in inhibiting gastric acid and pepsin secretion in man.
Methods
The experiments were done in eight healthy male volunteers aged 263 ± 14 years (range 20-31 years) and weighing 67.4+2.2 kg (range 61-79 kg). The protocol was approved by the ethical committee of the medical faculty of the University of Tubingen, and written informed consent was obtained from each individual. The protocol was as follows: after an overnight fast a nasogastric tube was placed into the stomach and the correct position was tested by repeated suction. At the beginning and at the end of the study laboratory data were within the normal range.
Discussion
The results have shown that ranitidine and cimetidine both effectively inhibit pentagastrin-stimulated volume, acid and pepsin secretion in normal volunteers. From the normalised data a parallel dose response relationship for all three secretion variables is evident. The relative potencies of both drugs as calculated from ID50s differ from those published so far.23 This is probably because in none of the studies dealing with dose comparison was a dose response relationship over a wide submaximal range of both drugs established. All secretory components (fluid, acid, and pepsin) were almost equally affected by both drugs in their effective dose range. From the present study no conclusions can be drawn as to whether the two drugs differ in the extent of maximal inhibition they can produce: that is worth another study. From the time that has to elapse between maximal inhibition and recovery it looks as if there is no difference between the two drugs. That would reflect the almost identical half lives of both drugs. It has to be emphasised that, in this study, both compounds were given intravenously as a bolus injection. If the drugs differ in their bioavailability it might be necessary to correct the dose of ranitidine for oral administration according to these differences.
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